These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7756514

  • 21. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 22. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
    Payen MC, De Wit S, Sommereijns B, Clumeck N.
    Biomed Pharmacother; 1997 May; 51(10):439-45. PubMed ID: 9863502
    [Abstract] [Full Text] [Related]

  • 23. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
    Navin TR, Miller KD, Satriale RF, Lobel HO.
    Lancet; 1985 Jun 08; 1(8441):1332. PubMed ID: 2860516
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M, Stephenson K, Gauar S, Frenkel L.
    Pediatr Pulmonol Suppl; 1997 Jun 08; 16():199-200. PubMed ID: 9443273
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
    Kronawitter U, Bogner JR, Goebel FD.
    Clin Investig; 1992 Dec 08; 70(12):1089-91. PubMed ID: 1467635
    [Abstract] [Full Text] [Related]

  • 30. Treatment of Pneumocystis carinii pneumonia in infancy.
    Iváldy G, Páldy L.
    Natl Cancer Inst Monogr; 1976 Oct 08; 43():201-9. PubMed ID: 1087956
    [Abstract] [Full Text] [Related]

  • 31. Effects of aerosolized pentamidine in AIDS patients.
    Nardini S.
    Monaldi Arch Chest Dis; 1993 Oct 08; 48(1):100. PubMed ID: 8472056
    [No Abstract] [Full Text] [Related]

  • 32. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD, Easterbrook PJ.
    J Antimicrob Chemother; 1997 Sep 08; 40(3):315-8. PubMed ID: 9338481
    [No Abstract] [Full Text] [Related]

  • 33. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
    Dorrell L, McCallum AK, Snow MH, Ong EL.
    AIDS Patient Care; 1995 Oct 08; 9(5):224-8. PubMed ID: 11361401
    [No Abstract] [Full Text] [Related]

  • 34. A novel variety of atypical Pneumocystis carinii infection after long-term prophylactic pentamidine inhalation in an AIDS patient: large lower lobe pneumocystoma.
    Albrecht H, Stellbrink HJ, Fenske S, Koch J, Greten H.
    Clin Investig; 1993 Apr 08; 71(4):310-3. PubMed ID: 8471817
    [Abstract] [Full Text] [Related]

  • 35. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Cheung TW, Matta R, Neibart E, Hammer G, Chusid E, Sacks HS, Szabo S, Rose D.
    Clin Infect Dis; 1993 Jan 08; 16(1):22-5. PubMed ID: 8448314
    [Abstract] [Full Text] [Related]

  • 36. Aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia: what is the correct dose?
    Weiss PJ, Wallace MR.
    Clin Infect Dis; 1994 Feb 08; 18(2):257-8. PubMed ID: 8161641
    [No Abstract] [Full Text] [Related]

  • 37. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ.
    N Engl J Med; 1992 Dec 24; 327(26):1842-8. PubMed ID: 1448121
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Fansidar and Pneumocystis carinii pneumonia.
    Frissen PH, Stronkhorst A, Eeftinck Schattenkerk JK, Danner SA.
    Ann Intern Med; 1988 Apr 24; 108(4):638-9. PubMed ID: 3258139
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
    Falloon J, Lavelle J, Ogata-Arakaki D, Byrne A, Graziani A, Morgan A, Amantea MA, Ownby K, Polis M, Davey RT.
    Antimicrob Agents Chemother; 1994 Jul 24; 38(7):1580-7. PubMed ID: 7979291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.